These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3741725)

  • 41. Effects of torsemide on pharmacodynamics and pharmacokinetics of warfarin in humans and rats.
    Kim HO; Lee KE; Park HY; Lee NR; Oh BR; Chang BC; Gwak HS
    J Pharm Pharmacol; 2013 Aug; 65(8):1195-203. PubMed ID: 23837587
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Failure of pharmacogenetic-based dosing algorithms to identify older patients requiring low daily doses of warfarin.
    Schwartz JB; Kane L; Moore K; Wu AH
    J Am Med Dir Assoc; 2011 Nov; 12(9):633-8. PubMed ID: 21450231
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients.
    Miao L; Yang J; Huang C; Shen Z
    Eur J Clin Pharmacol; 2007 Dec; 63(12):1135-41. PubMed ID: 17899045
    [TBL] [Abstract][Full Text] [Related]  

  • 44. D-Dimer versus International Normalized Ratio of Prothrombin Time in Ischemic Stroke Patients Treated with Sufficient Warfarin.
    Yamamoto R; Nakae Y; Tanaka F; Johkura K
    J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1781-1785. PubMed ID: 27103270
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the anticoagulant effect and timing of the concomitant use of S-1 and warfarin.
    Suzuki S; Ikegawa K; Yamamoto K; Saito S
    J Int Med Res; 2016 Oct; 44(5):1123-1130. PubMed ID: 27553806
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predicting the warfarin maintenance dose in elderly inpatients at treatment initiation: accuracy of dosing algorithms incorporating or not VKORC1/CYP2C9 genotypes.
    Moreau C; Pautas E; Gouin-Thibault I; Golmard JL; Mahé I; Mulot C; Loriot MA; Siguret V
    J Thromb Haemost; 2011 Apr; 9(4):711-8. PubMed ID: 21255252
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimal initial dose adjustment of warfarin in orthopedic patients.
    Lenzini PA; Grice GR; Milligan PE; Gatchel SK; Deych E; Eby CS; Burnett RS; Clohisy JC; Barrack RL; Gage BF
    Ann Pharmacother; 2007 Nov; 41(11):1798-804. PubMed ID: 17911206
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of vinpocetine on warfarin-induced inhibition of coagulation.
    Hitzenberger G; Sommer W; Grandt R
    Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):323-8. PubMed ID: 2272713
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hereditary warfarin resistance. Investigation of a rare phenomenon.
    Alving BM; Strickler MP; Knight RD; Barr CF; Berenberg JL; Peck CC
    Arch Intern Med; 1985 Mar; 145(3):499-501. PubMed ID: 3977518
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lack of interaction between famotidine and warfarin.
    De Lepeleire I; Van Hecken A; Verbesselt R; Tjandra-Maga TB; Buntinx A; Distlerath L; De Schepper PJ
    Int J Clin Pharmacol Res; 1990; 10(3):167-71. PubMed ID: 2228341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. During warfarin induction, the Fiix-prothrombin time reflects the anticoagulation level better than the standard prothrombin time.
    Jonsson PI; Letertre L; Juliusson SJ; Gudmundsdottir BR; Francis CW; Onundarson PT
    J Thromb Haemost; 2017 Jan; 15(1):131-139. PubMed ID: 27774726
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cranberry does not affect prothrombin time in male subjects on warfarin.
    Li Z; Seeram NP; Carpenter CL; Thames G; Minutti C; Bowerman S
    J Am Diet Assoc; 2006 Dec; 106(12):2057-61. PubMed ID: 17126638
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Single-dose adjustment versus no adjustment of warfarin in stably anticoagulated patients with an occasional international normalized ratio (INR) out of range.
    Schulman S; Melinyshyn A; Ennis D; Rudd-Scott L
    Thromb Res; 2010 May; 125(5):393-7. PubMed ID: 19640572
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methods for Predicting Warfarin Dose Requirements.
    Saffian SM; Wright DF; Roberts RL; Duffull SB
    Ther Drug Monit; 2015 Aug; 37(4):531-8. PubMed ID: 25549208
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Paper-based dosing algorithms for maintenance of warfarin anticoagulation.
    Wilson SE; Costantini L; Crowther MA
    J Thromb Thrombolysis; 2007 Jun; 23(3):195-8. PubMed ID: 17186393
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fiix-prothrombin time versus standard prothrombin time for monitoring of warfarin anticoagulation: a single centre, double-blind, randomised, non-inferiority trial.
    Onundarson PT; Francis CW; Indridason OS; Arnar DO; Bjornsson ES; Magnusson MK; Juliusson SJ; Jensdottir HM; Vidarsson B; Gunnarsson PS; Lund SH; Gudmundsdottir BR
    Lancet Haematol; 2015 Jun; 2(6):e231-40. PubMed ID: 26688233
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rifampin and warfarin: a drug interaction.
    Romankiewicz JA; Ehrman M
    Ann Intern Med; 1975 Feb; 82(2):224-5. PubMed ID: 1115445
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predicting warfarin maintenance dosage based on initial response.
    Miller DR; Brown MA
    Am J Hosp Pharm; 1979 Oct; 36(10):1351-5. PubMed ID: 507078
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation.
    Koefoed BG; Feddersen C; Gulløv AL; Petersen P
    Thromb Haemost; 1997 May; 77(5):845-8. PubMed ID: 9184390
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of Drug-Drug Interaction between Warfarin and Aprepitant and Its Effects on PT-INR of Patients Receiving Anticancer Chemotherapy.
    Takaki J; Ohno Y; Yamada M; Yamaguchi R; Hisaka A; Suzuki H
    Biol Pharm Bull; 2016 May; 39(5):863-8. PubMed ID: 26948084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.